Pathology
Alpha-methylacyl coenzyme A racemase (AMACR) is a novel immunomarker for prostatic adenocarcinoma that has recently been shown to be expressed in a number of malignancies including colorectal adenocarcinoma.
high expression in
- colorectal adenocarcinomas (62%) (15958853)
- non-ampullary (low frequency) (4%) (15958853)
- ampullary small intestinal adenocarcinoma (low frequency) (6%) (15958853)
- prostatic carcinoma
- high-grade prostatic intraepithelial neoplasia (PIN) (15297968)
- prostatic nephrogenic adenoma
- papillary renal cell carcinoma (14707866)